Gili Medical Ltd.

www.gili-medical.com

High-Tech Company

Ceased to Operate Q1/2019

Graduated from: Yozmot HaEmek

TECH VERTICALS

Diabetes, Digital Health, Health, Healthtech, IoT, Life Sciences, Medical Devices, MedTech, Quantified Self, Vertical Industries

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2010
Number of Employees	7
Reg. Number:	abCDe

DESCRIPTION

Gili Medical is a clinical stage, digital health companyin the field of diabetes.
Gili’s flagship product, the Night Watch™, is a non-invasive wristwatch to predict and alert dangerous nocturnal hypoglycemic events for diabetics. It incorporates a sophisticated and proprietary algorithm that uses data fusion and analysis of physiological parameters such as heart rate, peripheral vasoconstriction, body movements, and perspiration.

TECHNOLOGY

Non-invasive wristwatch for continuous monitoring and detection of nocturnal hypoglycemia.

Products and Phases

Product	Phase
Night Watch	Phase I
Continuous, non-invasive detection of nocturnal hypoglycemia.

	TARGET MARKETS
	People with diabetes.

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Kfar Saba, Israel

Address	21 Atir Yeda St.
City	Kfar Saba
Country	Israel
Zip	4464316

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Amir Schechter	Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

Feb. 26, 2015

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe

First Round

Oct. 01, 2012

R&D

abCDe

Seed

Apr. 14, 2010

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

R&D Grant

Apr. 14, 2010

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D grant ($0.43m)

Last Updated:	abCDe
IVC Number:	abCDe